Viromed Medical (DUSE:Q11) - Stock Price, News & Analysis

Q11 Stock Overview

Engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. More details

Q11 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Has not reported any financial data

Does not have a meaningful market cap (€41M)

Viromed Medical AG Competitors

aap Implantate

XTRA:AAQ1

€22.0m

NanoRepro

XTRA:NN6

€20.3m

Geratherm Medical

XTRA:GME

€14.6m

PULSION Medical Systems

MUN:PUS

€134.4m

Price History & Performance

Summary of all time highs, changes and price drops for Viromed Medical
Historical stock prices
Current Share Price	€2.38
52 Week High	€5.60
52 Week Low	€1.50
Beta	0
11 Month Change	0%
3 Month Change	6.25%
1 Year Change	-13.14%
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	138.00%

Recent updates

Shareholder Returns

	Q11	DE Medical Equipment	DE Market
7D	0%	-2.5%	-1.3%
1Y	-13.1%	-8.4%	7.4%

Return vs Industry: Q11 underperformed the German Medical Equipment industry which returned -7.1% over the past year.

Return vs Market: Q11 underperformed the German Market which returned 7.1% over the past year.

Price Volatility

Is Q11's price volatile compared to industry and market?
Q11 volatility
Q11 Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	5.2%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.8%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: Q11's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine Q11's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2021	n/a	n/a	www.viromed-medical-ag.de

Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.

Viromed Medical AG Fundamentals Summary

How do Viromed Medical's earnings and revenue compare to its market cap?
Q11 fundamental statistics
Market cap	€40.50m
Earnings (TTM)	€0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is Q11 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
Q11 income statement (TTM)
Revenue	€0
Cost of Revenue	€0
Gross Profit	€0
Other Expenses	€0
Earnings	€0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did Q11 perform over the long term?

See historical performance and comparison

Viromed Medical DUSE:Q11 Stock Report